Endothelial CD40 Mediates Microvascular von Willebrand Factor-Dependent Platelet Adhesion Inducing Inflammatory Venothrombosis in ADAMTS13 Knockout Mice

Sibgha Tahir; Andreas H. Wagner; Steffen Dietzel; Hanna Mannell; Joachim Pircher; Ludwig T. Weckbach; Markus Hecker; Ulrich Pohl

doi:10.1055/s-0040-1702228

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2020; 120(03): 466-476
DOI: 10.1055/s-0040-1702228

Blood Cells, Inflammation and Infection

Georg Thieme Verlag KG Stuttgart · New York

Endothelial CD40 Mediates Microvascular von Willebrand Factor-Dependent Platelet Adhesion Inducing Inflammatory Venothrombosis in ADAMTS13 Knockout Mice

Authors

Sibgha Tahir

¹Walter Brendel Centre of Experimental Medicine and Biomedical Center, Ludwig-Maximilians-University of Munich, Germany

²Division of Cardiovascular Physiology, Institute of Physiology and Pathophysiology, Heidelberg University, Germany

³German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany
Andreas H. Wagner

²Division of Cardiovascular Physiology, Institute of Physiology and Pathophysiology, Heidelberg University, Germany
Steffen Dietzel

¹Walter Brendel Centre of Experimental Medicine and Biomedical Center, Ludwig-Maximilians-University of Munich, Germany
Hanna Mannell

¹Walter Brendel Centre of Experimental Medicine and Biomedical Center, Ludwig-Maximilians-University of Munich, Germany
Joachim Pircher

¹Walter Brendel Centre of Experimental Medicine and Biomedical Center, Ludwig-Maximilians-University of Munich, Germany

³German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany

⁴Medizinische Klinik und Poliklinik I, Klinikum der Universität, Ludwig-Maximilians-University, Munich, Germany
Ludwig T. Weckbach

¹Walter Brendel Centre of Experimental Medicine and Biomedical Center, Ludwig-Maximilians-University of Munich, Germany

³German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany

⁴Medizinische Klinik und Poliklinik I, Klinikum der Universität, Ludwig-Maximilians-University, Munich, Germany
Markus Hecker^*

²Division of Cardiovascular Physiology, Institute of Physiology and Pathophysiology, Heidelberg University, Germany

⁵German Centre for Cardiovascular Research, Partner Site Heidelberg-Mannheim, Heidelberg, Germany
Ulrich Pohl^*

¹Walter Brendel Centre of Experimental Medicine and Biomedical Center, Ludwig-Maximilians-University of Munich, Germany

³German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany

Abstract

Background von Willebrand factor (vWF) plays an important role in platelet activation. CD40–CD40 ligand (CD40L) induced vWF release has been described in large vessels and cultured endothelium, but its role in the microcirculation is not known. Here, we studied whether CD40 is expressed in murine microvessels in vivo, whether CD40L induces platelet adhesion and leukocyte activation, and how deficiency of the vWF cleaving enzyme ADAMTS13 affects these processes.

Methods and Results The role of CD40L in the formation of beaded platelet strings reflecting their adhesion to ultralarge vWF fibers (ULVWF) was analyzed in the murine cremaster microcirculation in vivo. Expression of CD40 and vWF was studied by immunohistochemistry in isolated and fixed cremasters. Microvascular CD40 was only expressed under inflammatory conditions and exclusively in venous endothelium. We demonstrate that CD40L treatment augmented the number of platelet strings, reflecting ULVWF multimer formation exclusively in venules and small veins. In ADAMTS13 knockout mice, the number of platelet strings further increased to a significant extent. As a consequence extensive thrombus formation was induced in venules of ADAMTS13 knockout mice. In addition, circulating leukocytes showed primary and rapid adherence to these platelet strings followed by preferential extravasation in these areas.

Conclusion CD40L is an important stimulus of microvascular endothelial ULVWF release, subsequent platelet string formation and leukocyte extravasation but only in venous vessels under inflammatory conditions. Here, the lack of ADAMTS13 leads to severe thrombus formation. The results identify CD40 expression and ADAMTS13 activity as important targets to prevent microvascular inflammatory thrombosis.

Keywords

von Willebrand factor - CD40–CD40 ligand - ADAMTS13 - platelets - endothelium - leukocytes - thrombosis - microcirculation

Volltext

Referenzen

References
1 von Brühl ML, Stark K, Steinhart A. , et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209 (04) 819-835
2 Granger DN, Vowinkel T, Petnehazy T. Modulation of the inflammatory response in cardiovascular disease. Hypertension 2004; 43 (05) 924-931
3 Jin R, Xiao AY, Song Z. , et al. Platelet CD40 mediates leukocyte recruitment and neointima formation after arterial denudation injury in atherosclerosis-prone mice. Am J Pathol 2018; 188 (01) 252-263
4 Chen J, Chung DW. Inflammation, von Willebrand factor, and ADAMTS13. Blood 2018; 132 (02) 141-147
5 Yeung J, Li W, Holinstat M. Platelet signaling and disease: targeted therapy for thrombosis and other related diseases. Pharmacol Rev 2018; 70 (03) 526-548
6 Zuchtriegel G, Uhl B, Puhr-Westerheide D. , et al. Platelets guide leukocytes to their sites of extravasation. PLoS Biol 2016; 14 (05) e1002459
7 Popa M, Tahir S, Elrod J. , et al. Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell-platelet-monocyte interaction. Proc Natl Acad Sci U S A 2018; 115 (24) E5556-E5565
8 Huo Y, Schober A, Forlow SB. , et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9 (01) 61-67
9 Patzelt J, Verschoor A, Langer HF. Platelets and the complement cascade in atherosclerosis. Front Physiol 2015; 6: 49
10 Schulz C, Massberg S. Platelets in atherosclerosis and thrombosis. Handb Exp Pharmacol 2012; (210) 111-133
11 Ahmadsei M, Lievens D, Weber C, von Hundelshausen P, Gerdes N. Immune-mediated and lipid-mediated platelet function in atherosclerosis. Curr Opin Lipidol 2015; 26 (05) 438-448
12 Karshovska E, Weber C, von Hundelshausen P. Platelet chemokines in health and disease. Thromb Haemost 2013; 110 (05) 894-902
13 Van Hinsbergh VW, Tasev D. Platelets and thromboxane receptors: pivotal players in arteriogenesis. Cardiovasc Res 2015; 107 (04) 400-402
14 Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev 2007; 21 (02) 99-111
15 Ho-Tin-Noé B, Demers M, Wagner DD. How platelets safeguard vascular integrity. J Thromb Haemost 2011; 9 (Suppl. 01) 56-65
16 Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115 (12) 3378-3384
17 Rack K, Huck V, Hoore M, Fedosov DA, Schneider SW, Gompper G. Margination and stretching of von Willebrand factor in the blood stream enable adhesion. Sci Rep 2017; 7 (01) 14278
18 Chen Y, Ruggeri ZM, Du X. 14-3-3 proteins in platelet biology and glycoprotein Ib-IX signaling. Blood 2018; 131 (22) 2436-2448
19 Huck V, Schneider MF, Gorzelanny C, Schneider SW. The various states of von Willebrand factor and their function in physiology and pathophysiology. Thromb Haemost 2014; 111 (04) 598-609
20 Bergmeier W, Piffath CL, Goerge T. , et al. The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis. Proc Natl Acad Sci U S A 2006; 103 (45) 16900-16905
21 Margraf A, Nussbaum C, Sperandio M. Ontogeny of platelet function. Blood Adv 2019; 3 (04) 692-703
22 Sanders YV, Eikenboom J, de Wee EM. , et al; WiN Study Group. Reduced prevalence of arterial thrombosis in von Willebrand disease. J Thromb Haemost 2013; 11 (05) 845-854
23 De Ceunynck K, De Meyer SF, Vanhoorelbeke K. Unwinding the von Willebrand factor strings puzzle. Blood 2013; 121 (02) 270-277
24 Lopes da Silva M, Cutler DF. von Willebrand factor multimerization and the polarity of secretory pathways in endothelial cells. Blood 2016; 128 (02) 277-285
25 Valentijn KM, van Driel LF, Mourik MJ. , et al. Multigranular exocytosis of Weibel-Palade bodies in vascular endothelial cells. Blood 2010; 116 (10) 1807-1816
26 Schneider SW, Nuschele S, Wixforth A. , et al. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers. Proc Natl Acad Sci U S A 2007; 104 (19) 7899-7903
27 Kragh T, Napoleone M, Fallah MA, Gritsch H, Schneider MF, Reininger AJ. High shear dependent von Willebrand factor self-assembly fostered by platelet interaction and controlled by ADAMTS13. Thromb Res 2014; 133 (06) 1079-1087
28 Ferrer-Marin F, Stanworth S, Josephson C, Sola-Visner M. Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice. Transfusion 2013; 53 (11) 2814-2821
29 Margraf A, Nussbaum C, Rohwedder I. , et al. Maturation of platelet function during murine fetal development in vivo. Arterioscler Thromb Vasc Biol 2017; 37 (06) 1076-1086
30 Katz JA, Moake JL, McPherson PD. , et al. Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma. Blood 1989; 73 (07) 1851-1858
31 Hellström-Westas L, Ley D, Berg AC, Kristoffersson AC, Holmberg L. VWF-cleaving protease (ADAMTS13) in premature infants. Acta Paediatr 2005; 94 (02) 205-210
32 Ferrer-Marin F, Chavda C, Lampa M, Michelson AD, Frelinger III AL, Sola-Visner M. Effects of in vitro adult platelet transfusions on neonatal hemostasis. J Thromb Haemost 2011; 9 (05) 1020-1028
33 Crawley JT, Lane DA, Woodward M, Rumley A, Lowe GD. Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack. J Thromb Haemost 2008; 6 (04) 583-588
34 Aibar J, Castro P, Espinosa G. , et al. ADAMTS-13 in critically Ill patients with septic syndromes and noninfectious systemic inflammatory response syndrome. Shock 2015; 43 (06) 556-562
35 Takaya H, Yoshiji H, Kawaratani H. , et al. Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failure. Biomed Rep 2017; 7 (03) 277-285
36 De Maeyer B, De Meyer SF, Feys HB. , et al. The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet-decorated VWF strings in vivo. J Thromb Haemost 2010; 8 (10) 2305-2312
37 Dong JF. Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions. J Thromb Haemost 2005; 3 (08) 1710-1716
38 Shim K, Anderson PJ, Tuley EA, Wiswall E, Sadler JE. Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress. Blood 2008; 111 (02) 651-657
39 Turner NA, Nolasco L, Ruggeri ZM, Moake JL. Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage. Blood 2009; 114 (24) 5102-5111
40 Shida Y, Nishio K, Sugimoto M. , et al. Functional imaging of shear-dependent activity of ADAMTS13 in regulating mural thrombus growth under whole blood flow conditions. Blood 2008; 111 (03) 1295-1298
41 Motto DG, Chauhan AK, Zhu G. , et al. Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J Clin Invest 2005; 115 (10) 2752-2761
42 Noone DG, Riedl M, Licht C. The role of von Willebrand factor in thrombotic microangiopathy. Pediatr Nephrol 2018; 33 (08) 1297-1307
43 Banno F, Chauhan AK, Miyata T. The function of ADAMTS13 in thrombogenesis in vivo: insights from mutant mice. Int J Hematol 2010; 91 (01) 30-35
44 Desch KC, Motto DG. Thrombotic thrombocytopenic purpura in humans and mice. Arterioscler Thromb Vasc Biol 2007; 27 (09) 1901-1908
45 Lorenzi O, Frieden M, Villemin P, Fournier M, Foti M, Vischer UM. Protein kinase C-delta mediates von Willebrand factor secretion from endothelial cells in response to vascular endothelial growth factor (VEGF) but not histamine. J Thromb Haemost 2008; 6 (11) 1962-1969
46 Xiong Y, Huo Y, Chen C. , et al. Vascular endothelial growth factor (VEGF) receptor-2 tyrosine 1175 signaling controls VEGF-induced von Willebrand factor release from endothelial cells via phospholipase C-gamma 1- and protein kinase A-dependent pathways. J Biol Chem 2009; 284 (35) 23217-23224
47 Mojiri A, Nakhaii-Nejad M, Phan WL. , et al. Hypoxia results in upregulation and de novo activation of von Willebrand factor expression in lung endothelial cells. Arterioscler Thromb Vasc Biol 2013; 33 (06) 1329-1338
48 Möller K, Adolph O, Grünow J. , et al. Mechanism and functional impact of CD40 ligand-induced von Willebrand factor release from endothelial cells. Thromb Haemost 2015; 113 (05) 1095-1108
49 Henn V, Slupsky JR, Gräfe M. , et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391 (6667): 591-594
50 Mobarrez F, Sjövik C, Soop A. , et al. CD40L expression in plasma of volunteers following LPS administration: A comparison between assay of CD40L on platelet microvesicles and soluble CD40L. Platelets 2015; 26 (05) 486-490
51 Michel NA, Zirlik A, Wolf D. CD40L and Its Receptors in Atherothrombosis-An Update. Front Cardiovasc Med 2017; 4: 40
52 Karmann K, Hughes CC, Schechner J, Fanslow WC, Pober JS. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci U S A 1995; 92 (10) 4342-4346
53 Krzesz R, Wagner AH, Cattaruzza M, Hecker M. Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor kappaB and signal transducer and activation of transcription-1. FEBS Lett 1999; 453 (1-2): 191-196
54 Chakrabarti S, Rizvi M, Pathak D, Kirber MT, Freedman JE. Hypoxia influences CD40-CD40L mediated inflammation in endothelial and monocytic cells. Immunol Lett 2009; 122 (02) 170-184
55 Garlichs CD, Geis T, Goppelt-Struebe M. , et al. Induction of cyclooxygenase-2 and enhanced release of prostaglandin E(2) and I(2) in human endothelial cells by engagement of CD40. Atherosclerosis 2002; 163 (01) 9-16
56 Miller DL, Yaron R, Yellin MJ. CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression. J Leukoc Biol 1998; 63 (03) 373-379
57 Schönbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001; 58 (01) 4-43
58 Dormond O, Contreras AG, Meijer E. , et al. CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo. J Immunol 2008; 181 (11) 8088-8095
59 Song Z, Zhu X, Jin R. , et al. Roles of the kinase TAK1 in CD40-mediated effects on vascular oxidative stress and neointima formation after vascular injury. PLoS One 2014; 9 (07) e101671
60 Browatzki M, Pfeiffer CA, Schmidt J, Kranzhöfer R. Endothelin-1 induces functionally active CD40 protein via nuclear factor-kappaB in human vascular smooth muscle cells. Eur J Med Res 2007; 12 (03) 129-133
61 Hassan GS, Merhi Y, Mourad W. CD40 ligand: a neo-inflammatory molecule in vascular diseases. Immunobiology 2012; 217 (05) 521-532
62 Stokes KY, Calahan L, Hamric CM, Russell JM, Granger DN. CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation. Am J Physiol Heart Circ Physiol 2009; 296 (03) H689-H697
63 Mach F, Schönbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998; 394 (6689): 200-203
64 Korff T, Aufgebauer K, Hecker M. Cyclic stretch controls the expression of CD40 in endothelial cells by changing their transforming growth factor-beta1 response. Circulation 2007; 116 (20) 2288-2297
65 Myers TO, Joyner WL, Gilmore JP. Angiotensin reactivity in the cheek pouch of the renovascular hypertensive hamster. Hypertension 1988; 12 (04) 373-379
66 Baez S. An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc Res 1973; 5 (03) 384-394
67 Koch E, Pircher J, Czermak T. , et al. The endothelial tyrosine phosphatase SHP-1 plays an important role for vascular haemostasis in TNFα -induced inflammation in vivo. Mediators Inflamm 2013; 2013: 279781
68 Hassan GS, Merhi Y, Mourad WM. CD154 and its receptors in inflammatory vascular pathologies. Trends Immunol 2009; 30 (04) 165-172
69 Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev 2009; 229 (01) 152-172
70 Vanichakarn P, Blair P, Wu C, Freedman JE, Chakrabarti S. Neutrophil CD40 enhances platelet-mediated inflammation. Thromb Res 2008; 122 (03) 346-358
71 van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000; 67 (01) 2-17
72 Cabral-Marques O, França TT, Al-Sbiei A. , et al. CD40 ligand deficiency causes functional defects of peripheral neutrophils that are improved by exogenous IFN-γ. J Allergy Clin Immunol 2018; 142 (05) 1571-1588
73 Yellin MJ, Brett J, Baum D. , et al. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J Exp Med 1995; 182 (06) 1857-1864
74 Hollenbaugh D, Mischel-Petty N, Edwards CP. , et al. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995; 182 (01) 33-40
75 Häkkinen T, Karkola K, Ylä-Herttuala S. Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII). Virchows Arch 2000; 437 (04) 396-405
76 Kapur R, Zufferey A, Boilard E, Semple JW. Nouvelle cuisine: platelets served with inflammation. J Immunol 2015; 194 (12) 5579-5587
77 Vowinkel T, Wood KC, Stokes KY, Russell J, Krieglstein CF, Granger DN. Differential expression and regulation of murine CD40 in regional vascular beds. Am J Physiol Heart Circ Physiol 2006; 290 (02) H631-H639
78 Wagner AH, Gebauer M, Pollok-Kopp B, Hecker M. Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1. Blood 2002; 99 (02) 520-525
79 Geraldes P, Gagnon S, Hadjadj S. , et al. Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: an ERalpha-mediated pathway. Cardiovasc Res 2006; 71 (03) 566-573
80 Schönbeck U, Gerdes N, Varo N. , et al. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells. Circulation 2002; 106 (23) 2888-2893
81 André P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 2002; 106 (08) 896-899
82 Zirlik A, Bavendiek U, Libby P. , et al. TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells. Arterioscler Thromb Vasc Biol 2007; 27 (05) 1101-1107
83 Léveillé C, Bouillon M, Guo W. , et al. CD40 ligand binds to alpha5beta1 integrin and triggers cell signaling. J Biol Chem 2007; 282 (08) 5143-5151
84 Goerge T, Kleinerüschkamp F, Barg A. , et al. Microfluidic reveals generation of platelet-strings on tumor-activated endothelium. Thromb Haemost 2007; 98 (02) 283-286
85 Kerk N, Strozyk EA, Pöppelmann B, Schneider SW. The mechanism of melanoma-associated thrombin activity and von Willebrand factor release from endothelial cells. J Invest Dermatol 2010; 130 (09) 2259-2268
86 Rybaltowski M, Suzuki Y, Mogami H. , et al. In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall. Pflugers Arch 2011; 461 (06) 623-633
87 Chauhan AK, Goerge T, Schneider SW, Wagner DD. Formation of platelet strings and microthrombi in the presence of ADAMTS-13 inhibitor does not require P-selectin or beta3 integrin. J Thromb Haemost 2007; 5 (03) 583-589
88 Grässle S, Huck V, Pappelbaum KI. , et al. von Willebrand factor directly interacts with DNA from neutrophil extracellular traps. Arterioscler Thromb Vasc Biol 2014; 34 (07) 1382-1389
89 Pircher J, Engelmann B, Massberg S, Schulz C. Platelet-neutrophil crosstalk in atherothrombosis. Thromb Haemost 2019; 119 (08) 1274-1282
90 Zuchtriegel G, Uhl B, Hessenauer ME. , et al. Spatiotemporal expression dynamics of selectins govern the sequential extravasation of neutrophils and monocytes in the acute inflammatory response. Arterioscler Thromb Vasc Biol 2015; 35 (04) 899-910
91 Nicolay JP, Thorn V, Daniel C. , et al. Cellular stress induces erythrocyte assembly on intravascular von Willebrand factor strings and promotes microangiopathy. Sci Rep 2018; 8 (01) 10945
92 Portillo JA, Greene JA, Okenka G. , et al. CD40 promotes the development of early diabetic retinopathy in mice. Diabetologia 2014; 57 (10) 2222-2231
93 Steven S, Dib M, Hausding M. , et al. CD40L controls obesity-associated vascular inflammation, oxidative stress, and endothelial dysfunction in high fat diet-treated and db/db mice. Cardiovasc Res 2018; 114 (02) 312-323

Zusatzmaterial

Supplementary Material (PDF)